Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RTsafe is a private medical technology company focused on radiation oncology quality assurance and patient safety. The company develops and commercializes patient-specific and generic 3D-printed dosimetry phantoms, remote dosimetry services, and end-to-end treatment verification tools used by radiotherapy clinics and equipment manufacturers. Its flagship PseudoPatient platform uses real patient anatomical data and 3D printing to simulate radiotherapy workflows before treatment is delivered, with a particular early focus on brain radiotherapy. RTsafe has FDA-cleared personalized phantom technology, operates internationally from Greece with additional presence in the United States and Ireland, and serves hospitals, academic centers, and radiotherapy professionals. The business is best characterized as a commercial medtech platform company rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RTsafe.